Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up

Blood Cancer J. 2021 Feb 8;11(2):17. doi: 10.1038/s41408-021-00419-1.

¹ Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. eemanasanch@mdanderson.org.
² Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Faculty of Medicine Siriraj Hospital, Division of Hematology, Mahidol University, Salaya, Thailand.
⁴ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Radiodiagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁶ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

^# Contributed equally.

No abstract available

Publication types